Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Group" or the "Company")
Result of AGM
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company, specialising in artificial intelligence (AI) software and simulation, announces that at the AGM held earlier today, all resolutions were duly passed.
The voting results are displayed below.
| Resolution | For | For % | Discretion | Against | Against % | Withheld |
| 1 | 123,758,015 | 99.99 | 0 | 6,657 | 0.01 | 0 |
| 2 | 123,740,015 | 99.99 | 0 | 6,657 | 0.01 | 18,000 |
| 3 | 123,740,015 | 99.99 | 0 | 6,657 | 0.01 | 18,000 |
| 4 | 123,758,015 | 99.99 | 0 | 6,657 | 0.01 | 0 |
| 5 | 123,758,015 | 99.99 | 0 | 6,657 | 0.01 | 0 |
| 6 | 123,740,015 | 99.99 | 0 | 6,657 | 0.01 | 18,000 |
| 7 | 123,740,015 | 99.99 | 0 | 6,657 | 0.01 | 18,000 |
| 8 | 96,476,779 | 77.96 | 0 | 27,269,893 | 22.04 | 18,000 |
| 9 | 123,740,015 | 99.98 | 0 | 24,657 | 0.02 | 0 |
| 10 | 123,740,015 | 99.99 | 0 | 6,657 | 0.01 | 18,000 |
| 11 | 123,740,015 | 99.98 | 0 | 24,657 | 0.02 | 0 |
| 12 | 123,758,015 | 99.99 | 0 | 6,657 | 0.01 | 0 |
| 13 | 116,954,515 | 94.5 | 0 | 6,810,157 | 5.5 | 0 |
For further information, please contact:
| Intelligent Ultrasound Group plc | |||||
| Stuart Gall, CEO | Tel: +44 (0)29 2075 6534 | ||||
| Helen Jones, CFO | | ||||
| | | ||||
|
| | ||||
| Cenkos Securities - Nominated Advisor and Broker | Tel: +44 (0)20 7397 8900 | ||||
| Giles Balleny / Max Gould (Corporate Finance) | | ||||
| Michael Johnson / Julian Morse (Sales) | | ||||
| | | ||||
|
| | ||||
| Walbrook PR | Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com | ||||
| Paul McManus | Mob: +44 (0)7980 541 893 | ||||
| | | | | | |
ABOUT INTELLIGENT ULTRASOUND GROUP
Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through simulation. Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,450 simulators have been sold to over 700 medical institutions around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson Expert 22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound image interpretation by providing the user with real-time AI-based anatomy highlighting for a range of ultrasound guided regional anesthesia procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
